Related Experiment Video
Updated: May 24, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Detection of orphan receptor tyrosine kinase (ROR-1) expression in Egyptian pediatric acute lymphoblastic leukemia
1Department of Clinical and Chemical Pathology, Cairo University, Cairo, Egypt. iman.shym@yahoo.com
Abstract:
Receptor tyrosine kinases, a group of tumor-associated antigens, were introduced as targets for cancer intervention strategies. The human orphan receptor tyrosine kinase-1 (ROR-1) is a member of this family. Overexpression of ROR1 has been reported in B-cell chronic lymphocytic leukemia. The aim of this study was to detect the expression profile of ROR1 in 54 pediatric acute lymphoblastic leukemia (ALL) patients. ROR1 was overexpressed in ALL as the ROR1/ β-actin ratio was higher in ALL children than in control group (P = 0.024). ROR1 is a potential tool for targeted immunotherapy in pediatric ALL patients.
Insights
Receptor tyrosine kinase-1 (ROR1) is overexpressed in pediatric acute lymphoblastic leukemia (ALL). This finding suggests ROR1 may be a valuable target for developing new immunotherapies for ALL.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Receptor tyrosine kinases (RTKs) are key targets in cancer therapy.
- Human orphan receptor tyrosine kinase-1 (ROR1) is an RTK implicated in various cancers.
- ROR1 overexpression is observed in B-cell chronic lymphocytic leukemia.
Purpose of the Study:
- To investigate the expression profile of ROR1 in pediatric acute lymphoblastic leukemia (ALL).
- To assess the potential of ROR1 as a therapeutic target in pediatric ALL.
Main Methods:
- Quantitative analysis of ROR1 expression.
- Comparison of ROR1 levels between pediatric ALL patients and a control group.
- Utilized ROR1/β-actin ratio for expression quantification.
Main Results:
- ROR1 was significantly overexpressed in pediatric ALL patients compared to the control group (P = 0.024).
- The ROR1/β-actin ratio was elevated in children with ALL.
Conclusions:
- ROR1 is overexpressed in pediatric ALL, indicating its potential as a tumor-associated antigen.
- ROR1 represents a promising target for developing novel immunotherapies for pediatric ALL.
Related Concept Videos
Receptor Tyrosine Kinases
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

